{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T23:35:17Z","timestamp":1774740917016,"version":"3.50.1"},"reference-count":38,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Over the last few years, certain areas in the management nasopharyngeal carcinoma (NPC) that have an impact on the care of these patients have evolved, particularly with regard to liquid biopsies, minimally invasive surgery, and advances in chemotherapy and immunotherapy. Beyond its proven role in the diagnostics, surveillance, and treatment of NPC, liquid biopsy with plasma Epstein\u2013Barr virus DNA in the screening of high-risk populations for NPC is strongly supported by recent evidence. Surgery of the nasopharynx is reserved for locally recurrent NPC, and in recent years there have been great strides in minimally invasive techniques with survival rates similar to those of open techniques in treating NPC. Induction chemotherapy in a recent pooled analysis was shown to be superior to concurrent chemotherapy alone for locoregionally advanced NPC. Finally, immunotherapy with a PD-1 inhibitor in NPC has been shown to have 1-year overall survival rates comparable to those of other patients with heavily pre-treated metastatic or recurrent NPC. In this commentary, we discuss these recent advances and their potential in the clinical management of patients with NPC.<\/ns4:p>","DOI":"10.12688\/f1000research.15066.1","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T07:10:44Z","timestamp":1542784244000},"page":"1829","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":93,"title":["Recent advances in the management of nasopharyngeal carcinoma"],"prefix":"10.12688","volume":"7","author":[{"given":"W. K. Jacky","family":"Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9480-4637","authenticated-orcid":false,"given":"Jason Y. K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"114-9","DOI":"10.5732\/cjc.010.10377","article-title":"The prevalence and prevention of nasopharyngeal carcinoma in China.","volume":"30","author":"S Cao","year":"2011","journal-title":"Chin J Cancer."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"421-9","DOI":"10.1016\/S1044579X02000858","article-title":"Epidemiology of nasopharyngeal carcinoma.","volume":"12","author":"M Yu","year":"2002","journal-title":"Semin Cancer Biol."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"486-94","DOI":"10.1002\/ijc.2910200403","article-title":"Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination.","volume":"20","author":"M Andersson-Anvret","year":"1977","journal-title":"Int J Cancer."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"866-71","DOI":"10.1038\/ng.3006","article-title":"The genomic landscape of nasopharyngeal carcinoma.","volume":"46","author":"D Lin","year":"2014","journal-title":"Nat Genet."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"603-9","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<603::AID-IJC1>3.0.CO;2-H","article-title":"Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan.","volume":"86","author":"M Ward","year":"2000","journal-title":"Int J Cancer."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"245-7","DOI":"10.1038\/newbio244245a0","article-title":"EB viral genomes in epithelial nasopharyngeal carcinoma cells.","volume":"244","author":"H Wolf","year":"1973","journal-title":"Nat New Biol."},{"key":"ref-7","first-page":"5452-5","article-title":"Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.","volume":"59","author":"Y Lo","year":"1999","journal-title":"Cancer Res."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"225-31","DOI":"10.1093\/jnci\/44.1.225","article-title":"Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.","volume":"44","author":"W Henle","year":"1970","journal-title":"J Natl Cancer Inst."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"655-60","DOI":"10.1038\/bjc.1976.228","article-title":"Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.","volume":"34","author":"H Ho","year":"1976","journal-title":"Br J Cancer."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"1429-37","DOI":"10.1002\/cncr.20129","article-title":"Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA.","volume":"100","author":"R Hong","year":"2004","journal-title":"Cancer."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"5414-8","DOI":"10.1200\/JCO.2006.07.7982","article-title":"Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma.","volume":"24","author":"S Leung","year":"2006","journal-title":"J Clin Oncol."},{"key":"ref-12","first-page":"6878-81","article-title":"Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.","volume":"60","author":"Y Lo","year":"2000","journal-title":"Cancer Res."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"1204-8","DOI":"10.1093\/annonc\/mdu117","article-title":"Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma.","volume":"25","author":"S Leung","year":"2014","journal-title":"Ann Oncol."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"2461-70","DOI":"10.1056\/NEJMoa032260","article-title":"Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.","volume":"350","author":"J Lin","year":"2004","journal-title":"N Engl J Med."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"513-22","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.","volume":"377","author":"K Chan","year":"2017","journal-title":"N Engl J Med."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"602-9","DOI":"10.1177\/0194599813520136","article-title":"Trans-oral brush biopsies and quantitative PCR for EBV DNA detection and screening of nasopharyngeal carcinoma.","volume":"150","author":"R Ng","year":"2014","journal-title":"Otolaryngol Head Neck Surg."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"E1301-4","DOI":"10.1002\/hed.24216","article-title":"Use of transoral nasopharyngeal brush biopsy for Epstein-Barr virus DNA detection of local recurrence of nasopharyngeal carcinoma after radiotherapy.","volume":"38 Suppl 1","author":"J Lam","year":"2016","journal-title":"Head Neck."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"E5115-E5124","DOI":"10.1073\/pnas.1804184115","article-title":"Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.","volume":"115","author":"W Lam","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"1305-14","DOI":"10.1158\/1078-0432.CCR-17-1929","article-title":"Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.","volume":"24","author":"A Coghill","year":"2018","journal-title":"Clin Cancer Res."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"149-62","DOI":"10.1002\/ijc.30418","article-title":"Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.","volume":"140","author":"O Ramayanti","year":"2017","journal-title":"Int J Cancer."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"542-50","DOI":"10.1158\/1940-6207.CAPR-17-0035","article-title":"Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China.","volume":"10","author":"H Chen","year":"2017","journal-title":"Cancer Prev Res (Phila)."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1-9","DOI":"10.1016\/j.critrevonc.2016.04.006","article-title":"MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review.","volume":"103","author":"K Lee","year":"2016","journal-title":"Crit Rev Oncol Hematol."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"844-8","DOI":"10.1007\/s00268-003-7110-9","article-title":"Cancer of the nasopharynx: functional surgical salvage.","volume":"27","author":"W Wei","year":"2003","journal-title":"World J Surg."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"212-7","DOI":"10.1007\/s10147-011-0276-5","article-title":"A retrospective study of salvage surgery for recurrent nasopharyngeal carcinoma.","volume":"17","author":"X Bian","year":"2012","journal-title":"Int J Clin Oncol."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"475-91","DOI":"10.1007\/s11864-013-0261-5","article-title":"Current treatment options for local residual nasopharyngeal carcinoma.","volume":"14","author":"S Stoker","year":"2013","journal-title":"Curr Treat Options Oncol."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"834-42","DOI":"10.1007\/s10147-017-1143-9","article-title":"Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience.","volume":"22","author":"J Liu","year":"2017","journal-title":"Int J Clin Oncol."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"425-32","DOI":"10.1002\/alr.21881","article-title":"Endoscopic nasopharyngectomy in recurrent nasopharyngeal carcinoma: a case series, literature review, and pooled analysis.","volume":"7","author":"A Vlantis","year":"2017","journal-title":"Int Forum Allergy Rhinol."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"1386-91","DOI":"10.1002\/lary.26993","article-title":"Three-dimensional endoscopy for endoscopic salvage nasopharyngectomy: Preliminary report of experience.","volume":"128","author":"J Chan","year":"2018","journal-title":"Laryngoscope."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"275-81","DOI":"10.1007\/s00405-016-4248-2","article-title":"A preliminary report on the role of endoscopic endonasal nasopharyngectomy in recurrent rT3 and rT4 nasopharyngeal carcinoma.","volume":"274","author":"E Wong","year":"2017","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"399-406","DOI":"10.1016\/j.radonc.2015.04.024","article-title":"Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma \u2013 A case-matched comparison.","volume":"115","author":"R You","year":"2015","journal-title":"Radiother Oncol."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"788-93","DOI":"10.1002\/hed.23672","article-title":"Early results of robotic assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma.","volume":"37","author":"R Tsang","year":"2015","journal-title":"Head Neck."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"318-22","DOI":"10.1002\/lary.24918","article-title":"Transoral palate-sparing nasopharyngectomy with the Flex\u00ae System: preclinical study.","volume":"125","author":"J Richmon","year":"2015","journal-title":"Laryngoscope."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"2257-62","DOI":"10.1002\/lary.25970","article-title":"Transoral endoscopic nasopharyngectomy with a flexible next-generation robotic surgical system.","volume":"126","author":"R Tsang","year":"2016","journal-title":"Laryngoscope."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"3993-6","DOI":"10.1007\/s00405-017-4729-y","article-title":"Early results of a safety and feasibility clinical trial of a novel single-port flexible robot for transoral robotic surgery.","volume":"274","author":"J Chan","year":"2017","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"E1404-12","DOI":"10.1002\/hed.24234","article-title":"Extracranial\/intracranial vascular bypass and craniofacial resection: New hope for patients with locally advanced recurrent nasopharyngeal carcinoma.","volume":"38 Suppl 1","author":"J Chan","year":"2016","journal-title":"Head Neck."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"1824-33","DOI":"10.1158\/1078-0432.CCR-17-2656","article-title":"Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials.","volume":"24","author":"Y Chen","year":"2018","journal-title":"Clin Cancer Res."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"1412-8","DOI":"10.1200\/JCO.2017.77.0388","article-title":"Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).","volume":"36","author":"B Ma","year":"2018","journal-title":"J Clin Oncol."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40425-016-0153-x","article-title":"PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?","volume":"4","author":"C Grigg","year":"2016","journal-title":"J Immunother Cancer."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/7-1829\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1829\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1829\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T12:15:56Z","timestamp":1553861756000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/7-1829\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":38,"URL":"https:\/\/doi.org\/10.12688\/f1000research.15066.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.16403.r40796","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.16403.r40795","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/7-1829\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.16403.r40795, Jun Ma, Department of Radiation Oncology, Sun Yat-Sen University Cancer Center & State Key Laboratory of Oncology in South China, Guangdong, China, 21 Nov 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1829\/v1#referee-response-40795","order":0,"name":"referee-response-40795","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.16403.r40796, Anna Coghill, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA, 21 Nov 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1829\/v1#referee-response-40796","order":1,"name":"referee-response-40796","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}